Last update July 15, 2015

Deflazacort

Low Risk

Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

Drug which is oxazolinic-derived from Prednisolone with similar properties to the latter.

At latest update no published data on excretion into breast milk were found.

Due to a moderate high molecular weight and rapid elimination time it is probably safe while breastfeeding, mostly in non long-term treatments.
Until more data on this drug is available, it would be preferred other options that are known to be safer, specially during the neonatal period and prematurity.

Alternatives

  • Prednisolone ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Prednisone ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Deflazacort is also known as


Deflazacort in other languages or writings:

Group

Deflazacort belongs to this group or family:

Tradenames

Main tradenames from several countries containing Deflazacort in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 68 %
Molecular weight 442 daltons
Protein Binding 40 %
Tmax 1.5 - 2 hours
1 - 2 hours

References

  1. eMC. Deflazacort. Drug Summary 2015 Full text (in our servers)
  2. AEMPS. Deflazacort. Ficha técnica. 2010 Full text (in our servers)
  3. Möllmann H, Hochhaus G, Rohatagi S, Barth J, Derendorf H. Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone. Pharm Res. 1995 Abstract
  4. Barbieri C, Baruto C, Sala M, Bigatti G, Parodi M, Bellini P, Bevilacqua M. Lack of effect of deflazacort, a novel glucocorticoid, on basal and TRH-stimulated prolactin and thyrotropin levels in healthy subjects. Eur J Clin Pharmacol. 1985 Abstract

Total visits

57,082

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM